Clearly this was glossed over by the media
See this article from Reuters
See this article from Reuters
FLU-LIKE MARKET
Analysts have said that Pfizer and other COVID-19 vaccine makers stand to reap billions of dollars from annual vaccine boosters over the next few years.
Pfizer is already planning for a potential clinical study of a fourth dose of the vaccine, which could generate the type of data to support annual vaccination, according to Pfizer Chief Scientific Officer Mikael Dolsten.
Pending that data, he said, the company could file for annual COVID-19 vaccinations before next year's flu season.
Analysts have said that Pfizer and other COVID-19 vaccine makers stand to reap billions of dollars from annual vaccine boosters over the next few years.
Pfizer is already planning for a potential clinical study of a fourth dose of the vaccine, which could generate the type of data to support annual vaccination, according to Pfizer Chief Scientific Officer Mikael Dolsten.
Pending that data, he said, the company could file for annual COVID-19 vaccinations before next year's flu season.


Comment